IFIH1 and dermatomyositis: We hypothesized that the third type of hypersensitivity in the Gell–Coombs classification (type III hypersensitivity) [14–16] is present in the lungs of patients with DM-ILD, especially in patients with anti-MDA5 autoantibodies.